Tsiftsis Dimitrios, Manioti Eleni Alexandra, Touris Georgios, Kyriakakis Eleftherios, Tsamopoulos Nikolaos, Gamvroudi Maria
Emergency Department, "Agios Panteleimon" General Hospital, Nikaia, Greece.
Emergency Department "Konstantopouleio - Patision" General Hospital, Nea Ionia, Greece.
Med Devices (Auckl). 2024 Mar 5;17:107-112. doi: 10.2147/MDER.S445075. eCollection 2024.
To evaluate if the Strokefinder MD 100 by Medfield Diagnostics AB can be used as a point of care device in overcrowded Emergency Departments (ED).
We used the strokefinder MD 100 by Medfield Diagnostics AB in two Greek National Health System (NHS) Hospitals Emergency Departments. Our research protocol was approved by local scientific and ethics committees. We prospectively enrolled 71 adult patients from two NHS emergency departments in whom stroke was included as a differential diagnosis after triage. The feasibility of using the Strokefinder MD 100 by Medfield Diagnostics AB in various emergency department settings was evaluated through a structured questionnaire.
The strokefinder MD 100 was used on 71 patients in various settings in the Emergency Department. In every case, the test was completed at the patient bedside without interfering with other ongoing and diagnostic and resuscitation procedures. There was no additional delay to patient care caused by performing the test when compared with current local Emergency Department practice and protocol. In almost 90% of the cases, a clear result was produced by the device.
The Strokefinder MD 100 can be safely used as a point of care device by all trained healthcare professionals, in the most overcrowded emergency department, in various ED locations.
Point of Care Systems, Cerebrovascular Stroke, Proof of Concept Study.
评估Medfield Diagnostics AB公司生产的Strokefinder MD 100能否作为人满为患的急诊科的即时检测设备。
我们在两家希腊国家卫生系统(NHS)医院的急诊科使用了Medfield Diagnostics AB公司生产的Strokefinder MD 100。我们的研究方案得到了当地科学和伦理委员会的批准。我们前瞻性地纳入了来自两家NHS急诊科的71名成年患者,这些患者在分诊后将中风列为鉴别诊断。通过一份结构化问卷评估在各种急诊科环境中使用Medfield Diagnostics AB公司生产的Strokefinder MD 100的可行性。
在急诊科的各种环境中,Strokefinder MD 100被用于71名患者。在每种情况下,检测均在患者床边完成,且未干扰其他正在进行的诊断和复苏程序。与当前当地急诊科的实践和方案相比,进行该检测未给患者护理带来额外延迟。在近90%的病例中,该设备得出了明确的结果。
所有经过培训的医护人员均可在人满为患的急诊科的各个位置安全地将Strokefinder MD 100用作即时检测设备。
即时检测系统、脑血管意外、概念验证研究